Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

PAVmed (PAVM) Return on Equity (2021 - 2025)

PAVmed has reported Return on Equity over the past 5 years, most recently at 0.09% for Q4 2025.

  • Quarterly results put Return on Equity at 0.09% for Q4 2025, up 960.0% from a year ago — trailing twelve months through Dec 2025 was 0.09% (up 960.0% YoY), and the annual figure for FY2025 was 0.25%, up 190.0%.
  • Return on Equity for Q4 2025 was 0.09% at PAVmed, down from 0.05% in the prior quarter.
  • Over the last five years, Return on Equity for PAVM hit a ceiling of 10.72% in Q3 2024 and a floor of 18.97% in Q2 2023.
  • Median Return on Equity over the past 5 years was 0.09% (2025), compared with a mean of 1.02%.
  • Biggest five-year swings in Return on Equity: crashed -1742bps in 2023 and later skyrocketed 2267bps in 2024.
  • PAVmed's Return on Equity stood at 0.98% in 2021, then tumbled by -434bps to 5.23% in 2022, then surged by 176bps to 3.98% in 2023, then plummeted by -344bps to 9.69% in 2024, then skyrocketed by 99bps to 0.09% in 2025.
  • The last three reported values for Return on Equity were 0.09% (Q4 2025), 0.05% (Q3 2025), and 0.22% (Q2 2025) per Business Quant data.